biOasis Technologies Ord Shs BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > Another Midatech Deal Coming for Bioasis??

<< Previous

Bullboard Posts

Next >>

Comment by ROSIE2023on Feb 15, 2023 5:56pm

75 Views

Post# 35288606

RE:RE:RE:Another Midatech Deal Coming for Bioasis??

The deal may have passed as per the vote but it would be hard for Drdr to go back and resurrect it given that they publically stated it was terminated
I have no problem with a modatexh deal but not on the bullshit terms previously described

<< Previous

Bullboard Posts

Next >>

Abcourt Mines launches Flordin property drill campaign